BEQOM
12.9.2019 15:02:08 CEST | Business Wire | Press release
beqom, a cloud-based compensation software provider, today announced that it has partnered with NGA Human Resources, a leading provider of digital HR and multi-country payroll services, to provide enterprise clients with a single best in class platform for managing Total Reward and compensation programs.
beqom’s platform is ideally suited to organizations that can’t compromise when it comes to maximizing their employee performance in line with their business strategy, by rewarding their employees to drive their satisfaction and trust, retain their talents and comply with security and pay equity requirements.
With immediate effect, NGA HR’s consultancy and delivery teams will integrate beqom’s Total Compensation Management Cloud Solution into existing and new cloud HR infrastructures to create a single platform for managing HR and sales compensation uniformly across all operating countries.
Data from all HR, workforce management and sales platforms is captured within the platform. The data can then be analyzed, cut and presented to provide real-time, retrospective or forward-looking analytics and planning. This single situational view will bring multiple benefits to NGA HR’s clients and their employees.
For the business, it makes it easy to understand the performance and retention returns on specific rewards and incentive programs. Budgets can be set against projected impact intelligence and what-if scenarios can simulate the potential of proposed rewards programs, for example, per employee population for country.
For employees, it presents the total value of rewards – addressing the compensation gap that sees many employees leaving organizations for perceived higher salaries. It also makes it very easy for employees to see what they need to achieve for financial reward. This can be a huge motivator and drive the efficiency of individuals and business groups.
For HR and rewards teams, the efficiency and performance gains are manifold. The platform addresses the challenges of managing multiple currencies, languages, time zones and rewards cultures across the business. It supports the local governance of global policies, and workflows ensure that all employees are rewarded fairly, compliantly and on time.
“beqom’s, Total Compensation Management Cloud Solution complements well our portfolio of HR technology and analytics solutions. Many of our clients already have the platform connecting some or all their country locations. For these, we can easily integrate the management of the platform into existing services,” explained Simon Porter, VP Digital HR at NGA Human Resources.
“For organizations looking to create visibility into rewards and compensation programs, we can build the platform into existing and new cloud HR infrastructures to provide the analytics, reporting, modeling and simulation capabilities enterprises need to maximize performance, increase retention, streamline costs and ensure compliance,” continued Simon Porter, VP Digital HR at NGA Human Resources.
"NGA HR has been successfully deploying HR technologies and running core HR processes for multi-national clients for many years. Knowing their clients’ needs for a reliable unified Total Rewards Management solution, NGA selected beqom as a key element of its HR services portfolio,” explained François D’Haegeleer, Global Head of Business Development at beqom.
About beqom
Happiness is the best driver for success.
Our mission is to make the workforce of our customers happy. beqom drives happiness by allowing business managers to lead, align, and motivate employees and partners. beqom’s cloud-based total compensation platform is used globally across all industry sectors by over 100 large companies such as Microsoft and Vodafone. It addresses all performance and compensation aspects such as salary review, bonus, long-term incentives, commissions, benefits, non-cash rewards and all key drivers towards Employee Performance Management and Sales Performance Management. HR, sales, and finance leverage our platform to drive performance, retention, cost optimization, efficiency, compliance and… happiness among their people.
About NGA Human Resources
At NGA HR, our mission is to innovate HR & Payroll for today and tomorrow. We help our clients deliver seamless workforce and payroll services and empower HR as strategic partner for data-driven workforce decisions. As a result, HR leaders can offer better employee experiences, more easily attract and retain talent, manage the employee life cycle and support the globally connected, agile workforce.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190912005322/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom